Another mtDNA mutation affecting ND3 (A10398G) has been detected selectively in bone metastasis of 7/10 prostate cancer patients, suggesting that the A10398G mtDNA mutation may confer a selective advantage to prostate cancer cells to colonize the bone metastatic sites (55). This evidence concerns the gene MT-ND3 and prostate cancer.